2nd Quarter - Report
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
HHS rule related to expedited coverage of innovative technology.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
H.R. 184: Protect Medical Innovation Act. H.R.1645: Fostering Innovation Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Promoted life sciences community and communicated economic and health benefits of the industry. H.R.1628: American Health Care Act. H.R.2430/S.934: FDA Reauthorization Act of 2017. Education about the value of innovative new medicines. H.R.849/H.J.Res 51: IPAB Repeal Act and Joint Resolution related to IPAB Repeal.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.